212 related articles for article (PubMed ID: 38173037)
21. Propionate alleviates fatty acid-induced mitochondrial dysfunction, oxidative stress, and apoptosis by upregulating PPARG coactivator 1 alpha in hepatocytes.
Wang X; Zhu M; Loor JJ; Jiang Q; Zhu Y; Li W; Du X; Song Y; Gao W; Lei L; Wang J; Liu G; Li X
J Dairy Sci; 2022 May; 105(5):4581-4592. PubMed ID: 35181129
[TBL] [Abstract][Full Text] [Related]
22. Lanzhang Granules Ameliorate Nonalcoholic Fatty Liver Disease by Regulating the PPAR
Huang P; Yang L; Liu Y; Jiang Y; Li Y; Chen Z; Song H; Zheng P
Evid Based Complement Alternat Med; 2022; 2022():1124901. PubMed ID: 35035496
[TBL] [Abstract][Full Text] [Related]
23. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
[TBL] [Abstract][Full Text] [Related]
24. Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation.
Jin M; Feng H; Wang Y; Yan S; Shen B; Li Z; Qin H; Wang Q; Li J; Liu G
Oxid Med Cell Longev; 2020; 2020():2940746. PubMed ID: 32655764
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of hepatic CLOCK by PPARα is involved in inhibition of NAFLD.
Luo J; Yan Z; Dai M; Xu L; Zhang H; Xi Y; Yang J; Liu A
J Mol Med (Berl); 2023 Feb; 101(1-2):139-149. PubMed ID: 36527474
[TBL] [Abstract][Full Text] [Related]
26. Acute Elevated Resistin Exacerbates Mitochondrial Damage and Aggravates Liver Steatosis Through AMPK/PGC-1α Signaling Pathway in Male NAFLD Mice.
Wen F; Shi Z; Liu X; Tan Y; Wei L; Zhu X; Zhang H; Zhu X; Meng X; Ji W; Yang M; Lu Z
Horm Metab Res; 2021 Feb; 53(2):132-144. PubMed ID: 33302316
[TBL] [Abstract][Full Text] [Related]
27. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
Weng SW; Wu JC; Shen FC; Chang YH; Su YJ; Lian WS; Tai MH; Su CH; Chuang JH; Lin TK; Liou CW; Chu TH; Kao YH; Wang FS; Wang PW
Diabetologia; 2023 May; 66(5):913-930. PubMed ID: 36692509
[TBL] [Abstract][Full Text] [Related]
28. Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats.
Zhou C; Zhou J; Han N; Liu Z; Xiao B; Yin J
Int Immunopharmacol; 2015 Mar; 25(1):218-28. PubMed ID: 25661699
[TBL] [Abstract][Full Text] [Related]
29. PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease.
Huang K; Du M; Tan X; Yang L; Li X; Jiang Y; Wang C; Zhang F; Zhu F; Cheng M; Yang Q; Yu L; Wang L; Huang D; Huang K
J Hepatol; 2017 May; 66(5):962-977. PubMed ID: 27979751
[TBL] [Abstract][Full Text] [Related]
30. Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1α in db/db mice.
Hong YA; Lim JH; Kim MY; Kim TW; Kim Y; Yang KS; Park HS; Choi SR; Chung S; Kim HW; Kim HW; Choi BS; Chang YS; Park CW
PLoS One; 2014; 9(5):e96147. PubMed ID: 24801481
[TBL] [Abstract][Full Text] [Related]
31. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo.
Park MJ; Kim DI; Lim SK; Choi JH; Kim JC; Yoon KC; Lee JB; Lee JH; Han HJ; Choi IP; Kim HC; Park SH
J Hepatol; 2014 Nov; 61(5):1151-7. PubMed ID: 25003952
[TBL] [Abstract][Full Text] [Related]
32. Alternate-day fasting alleviates high fat diet induced non-alcoholic fatty liver disease through controlling PPARα/Fgf21 signaling.
Liu X; Zhang Y; Ma C; Lin J; Du J
Mol Biol Rep; 2022 Apr; 49(4):3113-3122. PubMed ID: 35107741
[TBL] [Abstract][Full Text] [Related]
33. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
34. Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21/PGC-1α pathway.
Wu L; Mo W; Feng J; Li J; Yu Q; Li S; Zhang J; Chen K; Ji J; Dai W; Wu J; Xu X; Mao Y; Guo C
Br J Pharmacol; 2020 Aug; 177(16):3760-3777. PubMed ID: 32446270
[TBL] [Abstract][Full Text] [Related]
35. Silybin alleviates hepatic lipid accumulation in methionine-choline deficient diet-induced nonalcoholic fatty liver disease in mice via peroxisome proliferator-activated receptor α.
Cui S; Pan XJ; Ge CL; Guo YT; Zhang PF; Yan TT; Zhou JY; He QX; Cheng LH; Wang GJ; Hao HP; Wang H
Chin J Nat Med; 2021 Jun; 19(6):401-411. PubMed ID: 34092291
[TBL] [Abstract][Full Text] [Related]
36. Jianpi Shengqing Huazhuo Formula improves abnormal glucose and lipid metabolism in obesity by regulating mitochondrial biogenesis.
Wang W; Chen S; Xu S; Liao G; Li W; Yang X; Li T; Zhang H; Huang H; Zhou Y; Pan H; Lin C
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117102. PubMed ID: 37660955
[TBL] [Abstract][Full Text] [Related]
37. Wild ginseng cambial meristematic cells ameliorate hepatic steatosis and mitochondrial dysfunction in high-fat diet-fed mice.
Lee SB; Cho HI; Jin YW; Lee EK; Ahn JY; Lee SM
J Pharm Pharmacol; 2016 Jan; 68(1):119-27. PubMed ID: 26806698
[TBL] [Abstract][Full Text] [Related]
38. Fenofibrate treatment attenuated chronic endoplasmic reticulum stress in the liver of nonalcoholic fatty liver disease mice.
Zhang N; Lu Y; Shen X; Bao Y; Cheng J; Chen L; Li B; Zhang Q
Pharmacology; 2015; 95(3-4):173-80. PubMed ID: 25896720
[TBL] [Abstract][Full Text] [Related]
39. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M
J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265
[TBL] [Abstract][Full Text] [Related]
40. Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway.
He Y; Yang W; Gan L; Liu S; Ni Q; Bi Y; Han T; Liu Q; Chen H; Hu Y; Long Y; Yang L
Gastroenterol Hepatol; 2021 May; 44(5):355-365. PubMed ID: 33272734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
